Orgenesis Inc.
ORGSOTCHealthcare● Active
$0.50
+$0.01(+1.02%)
Market Cap$2558779
P/E Ratio—
52W High$5.89
52W Low$0.02
Orgenesis Inc. (ORGS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ORGS · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.53M | $36.02M | $35.50M | $7.65M | $33.26M |
| Cost of Revenue | $6.25M | $20.44M | $28.16M | $31.10M | $18.12M |
| Gross Profit | ($5.72M) | $15.59M | $7.34M | ($23.45M) | $15.14M |
| Gross Margin %(computed) | — | 43.26% | 20.68% | -306.42% | 45.53% |
| Operating Expenses | |||||
| R&D Expenses | $11.09M | $6.01M | $36.64M | $83.99M | $12.46M |
| G&A Expenses | $34.62M | $16.16M | $15.40M | $19.35M | $25.25M |
| Total Operating Expenses | $47.91M | $22.95M | $50.02M | $103.43M | $39.74M |
| Operating Income | ($53.64M) | ($7.54M) | ($16.80M) | ($95.78M) | ($24.60M) |
| Operating Margin %(computed) | — | -20.93% | -47.32% | — | -73.98% |
| Interest Income | $0.00M | $1.82M | $0.00M | $0.00M | $0.50M |
| Interest Expense | $2.17M | $1.82M | $0.37M | $1.09M | $0.46M |
| Income Before Tax | ($64.44M) | ($11.96M) | ($17.95M) | ($96.74M) | ($25.48M) |
| Income Tax Expense | $0.47M | $0.21M | $0.11M | ($1.61M) | $0.56M |
| Net Income | ($55.36M) | ($14.89M) | ($18.06M) | ($95.81M) | ($26.04M) |
| Net Margin %(computed) | — | -41.33% | -50.87% | — | -78.30% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.91 | $-0.59 | $-0.74 | $-4.46 | $-1.64 |
| Wtd Avg Shares | 29.01M | 25.10M | 24.27M | 21.32M | 15.91M |
| EBITDA | ($60.72M) | ($8.16M) | ($15.72M) | ($94.21M) | ($18.91M) |
| EBITDA Margin %(computed) | — | -22.65% | -44.27% | — | -56.86% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Orgenesis Inc. data
About Orgenesis Inc. (ORGS) Income Statement
Orgenesis Inc. (ORGS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, ORGS reported revenue of $0.00B, gross profit of ($0.01B) (gross margin -1080.19%), and net income of ($0.06B) — a net profit margin of -10445.47%.
Frequently asked questions
ORGS · 4 questionsOrgenesis Inc. (ORGS) reported revenue of $0.00B for 2023, down 98.5% year-over-year.
ORGS revenueORGS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09